m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00043)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
hsa-miR-766-5p
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | METTL3-mediated m6A modification induced the aberrant expression of NEAT1 in chronic myelocytic leukemia. Overexpression of NEAT1 inhibited cell viability and promoted the apoptosis of chronic myelocytic leukemia cells. hsa-miR-766-5p was upregulated in CML PBMCs and abrogated the effects of NEAT1 on cell viability and apoptosis of the chronic myelocytic leukemia cells. | |||
| Target Regulation | Up regulation | |||
| Responsed Disease | Chronic myeloid leukaemia | ICD-11: 2B33.2 | ||
| Cell Process | Cell viability and apoptosis | |||
| In-vitro Model | BV-173 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0181 |
| K-562 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0004 | |
| KCL-22 | Chronic myelogenous leukemia | Homo sapiens | CVCL_2091 | |
| MEG-01 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0425 | |
Malignant haematopoietic neoplasm [ICD-11: 2B33]
| In total 1 item(s) under this disease | ||||
| Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | METTL3-mediated m6A modification induced the aberrant expression of NEAT1 in chronic myelocytic leukemia. Overexpression of NEAT1 inhibited cell viability and promoted the apoptosis of chronic myelocytic leukemia cells. hsa-miR-766-5p was upregulated in CML PBMCs and abrogated the effects of NEAT1 on cell viability and apoptosis of the chronic myelocytic leukemia cells. | |||
| Responsed Disease | Chronic myeloid leukaemia [ICD-11: 2B33.2] | |||
| Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
| Target Regulation | Up regulation | |||
| Cell Process | Cell viability and apoptosis | |||
| In-vitro Model | BV-173 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0181 |
| K-562 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0004 | |
| KCL-22 | Chronic myelogenous leukemia | Homo sapiens | CVCL_2091 | |
| MEG-01 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0425 | |
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Regulator
Non-coding RNA
m6A Regulator: Methyltransferase-like 3 (METTL3)
| In total 1 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT05503 | ||
| Epigenetic Regulator | hsa-miR-766-5p | |
| Regulated Target | Cyclin-dependent kinase inhibitor 1 (CDKN1A) | |
| Crosstalk relationship | m6A → ncRNA | |
| Disease | Chronic myeloid leukaemia | |